A Phase 3 Randomized, Open-label Study of OP-1250 Monotherapy vs Standard of Care for the Treatment of Subjects with HR+/HER2- LocallyAdvanced Breast Cancer Following CDK4/6 Inhibitor Therapy study

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine & Life Sciences